KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Depreciation & Amortization (CF) (2018 - 2025)

Exact Sciences (EXAS) has disclosed Depreciation & Amortization (CF) for 15 consecutive years, with $32.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 10.44% to $32.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $124.9 million through Dec 2025, up 4.35% year-over-year, with the annual reading at $124.9 million for FY2025, 4.33% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $32.1 million at Exact Sciences, up from $31.7 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $32.1 million in Q4 2025, with the low at $20.5 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $27.2 million, with a median of $28.3 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) grew 28.13% in 2021, then decreased 5.88% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $21.0 million in 2021, then rose by 26.51% to $26.6 million in 2022, then increased by 16.16% to $30.9 million in 2023, then fell by 5.88% to $29.0 million in 2024, then grew by 10.44% to $32.1 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $32.1 million, $31.7 million, and $31.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.